Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Recherche avancée dans les brevets | Historique Web | Connexion

Brevets

Référencé par

Brevet citant Date de dépôt Date de délivrance Cessionnaire d'origine Titre
US395174811 nov. 197420 avr. 1976Medical Products, Inc.Sensitized matrix for detection of disease
US40160434 sept. 19755 avr. 1977Akzona IncorporatedEnzymatic immunological method for the determination of antigens and antibodies
US403965211 oct. 19732 août 1977Miles Laboratories, Inc.Column method of immunoassay employing an immobilized binding partner
US411677619 avr. 197626 sept. 1978International Radioimmune Systems, Inc.Diagnostic blood test and kit for detecting human chorionic gonadotropin
US42005089 févr. 197829 avr. 1980Method and composition for detecting antigenic substances
US42038025 déc. 197720 mai 1980Syva CompanyInhibitable enzyme amplification assay
US42407519 nov. 197823 déc. 1980Akzona IncorporatedMethod and apparatus for specific binding substances
US42489653 oct. 19773 févr. 1981Mochida Seiyaku Kabushiki KaishaImmunochemical process of measuring physiologically active substances
US425422316 avr. 19793 mars 1981Akzona IncorporatedApparatus for colorimetric determination
US42699388 mars 197926 mai 1981Eastman Kodak CompanyAssay of peroxidatively active materials
US427514924 nov. 197823 juin 1981Syva CompanyMacromolecular environment control in specific receptor assays
US428974831 mai 197915 sept. 1981United States of AmericaUltrasensitive enzymatic radioimmunoassay method
US43025347 mars 197824 nov. 1981Israel Institute for Biological ResearchChemiluminescent enzyme immunoassay
US43187073 juin 19809 mars 1982Syva CompanyMacromolecular fluorescent quencher particle in specific receptor assays
US432364715 oct. 19806 avr. 1982University of MiamiSteric hindrance enzyme immunoassay
US43314443 mars 198025 mai 1982Fuji Photo Film Co., Ltd.Competitive immunoassay using silver halide fogging agent
US43370633 mars 198029 juin 1982Fuji Photo Film Co., Ltd.Competitive immunoassay using spectral sensitizer label
US43438961 mai 198010 août 1982Akzona IncorporatedMethod and test pack for the demonstration and determination of an antigen or antibody
US436253114 avr. 19817 déc. 1982Technicon Instruments CorporationAgglutination immunoassays carried out with agent to reduce non-specific interferences
US43749259 févr. 198122 févr. 1983Syva CompanyMacromolecular environment control in specific receptor assays
US43761104 août 19808 mars 1983Hybritech, IncorporatedImmunometric assays using monoclonal antibodies
US442427912 août 19823 janv. 1984QuidelRapid plunger immunoassay method and apparatus
US444623213 oct. 19811 mai 1984Enzyme immunoassay with two-zoned device having bound antigens
US444623825 janv. 19821 mai 1984Janssen Pharmaceutica N.V.Bright field light microscopic method of localizing tissue antigens
US445288621 sept. 19815 juin 1984Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
US446978714 mai 19824 sept. 1984Mallinckrodt Inc.Immunoassay involving soluble complex of second antibody and labeled binding protein
US447487829 sept. 19752 oct. 1984Cordis Laboratories, Inc.Sandwich EIA for antigen associated with hepatitis
US448653024 juin 19814 déc. 1984Hybritech IncorporatedImmunometric assays using monoclonal antibodies
US450314320 août 19825 mars 1985BTC Diagnostics Limited PartnershipEnzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
US450600930 mars 198219 mars 1985University of CaliforniaHeterogeneous immunoassay method
US451728823 janv. 198114 mai 1985American Hospital Supply Corp.Solid phase system for ligand assay
US453090013 sept. 198223 juil. 1985Seragen Diagnostics Inc.Soluble insoluble polymers in enzymeimmunoassay
US459299516 nov. 19833 juin 1986Dainippon Pharmaceutical Co., Ltd.Reagent for streptococcal anti-esterase assay
US46043651 juil. 19825 août 1986Electro-Nucleonics, Inc.Immunoprecipitation assay
US46422852 mai 198410 févr. 1987Diamedix CorporationSandwich EIA for antigen
US466502030 mai 198412 mai 1987United States Department of EnergyFlow cytometer measurement of binding assays
US471334714 janv. 198515 déc. 1987Sensor Diagnostics, Inc.Measurement of ligand/anti-ligand interactions using bulk conductance
US475387526 juil. 198528 juin 1988Method for assaying proteases with tagged proteinaceous inhibitors
US480852223 avr. 198628 févr. 1989Moskovsky Gosudarstvennx Universitet Imeni M. V. Lomonoso VAEnzyme immunoassays using inorganic pyrophosphatase
US481239519 août 198614 mars 1989E. I. Du Pont De Nemours and CompanyMethod for detecting enzymatic activity using particle agglutination
US48123962 juil. 198714 mars 1989E. I. Du Pont De Nemours and CompanyMethod for detecting enzymatic activity using particle agglutination
US48247849 nov. 198725 avr. 1989Hygeia Sciences, IncorporatedChromogenic solution for immunoassay
US486810812 déc. 198519 sept. 1989Hygeia Sciences, IncorporatedMultiple-antibody detection of antigen
US493138521 nov. 19885 juin 1990Hygeia Sciences, IncorporatedEnzyme immunoassays and immunologic reagents
US50473306 janv. 198810 sept. 1991Commissariat a l'Energie AtomiqueCompound labelled by the acetyl cholinesterase of Electrophorus electricus, its preparation process and its use as a tracer or marker in enzymoimmunological determinations
US510278828 avr. 19897 avr. 1992Hygeia Sciences, Inc.Immunoassay including lyophilized reactant mixture
US532882820 juil. 199212 juil. 1994Syntex (U.S.A.) Inc.Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
US53345133 sept. 19922 août 1994Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US534886715 nov. 199120 sept. 1994George GeorgiouExpression of proteins on bacterial surface
US545150710 mai 199419 sept. 1995Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US54686471 sept. 199421 nov. 1995Syntex (U.S.A.) Inc.Method for immunochromatographic analysis
US553440518 nov. 19949 juil. 1996The Scripps Research InstituteAntibodies, diagnostic systems and methods for assaying HBxAg
US561007719 juil. 199411 mars 1997Unilever Patent Holdings B.V.Processes and apparatus for carrying out specific binding assays
US561450421 avr. 199525 mars 1997The University of South FloridaMethod of making inosine monophosphate derivatives and immunopotentiating uses thereof
US56248095 mai 199529 avr. 1997Behringwerke AGDevice for immunochromatographic analysis
US567247520 janv. 199530 sept. 1997Chiron Diagnostics CorporationMixed luminescent conjugate test
US569868628 avr. 199516 déc. 1997Arch Development CorporationYeast telomerase compositions
US572601510 janv. 199510 mars 1998Vanderbilt UniversityMethod to determine metastatic potential of tumor cells
US57260236 juin 199510 mars 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US572880721 juin 199517 mars 1998Ramot-University Authority For Applied Research and Industrial Development, Ltd. Mutated proteins associated with ataxia-telangiectasia
US577709328 juil. 19957 juil. 1998RAMOT-University Authority for Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US580100531 mars 19951 sept. 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US58075524 août 199515 sept. 1998Board of Regents, The University of Texas SystemCompositions for conferring immunogenicity to a substance and uses thereof
US583753515 févr. 199617 nov. 1998Henry Ford Health SystemNeuronal-neonatal gene: neuronatin
US584032219 déc. 199624 nov. 1998Ramot-University Authority For Applied Research & Industrial Devel. Ltd.Anti-oral-microbial adhesion fraction derived from vaccinium
US58436737 juin 19951 déc. 1998Curators of the University of MissouriMethod of screening for endometriosis
US58465387 juin 19958 déc. 1998University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
US58586618 avr. 199612 janv. 1999RAMOT-University Authority for Applied Research and Industrial DevelopmentAtaxia-telangiectasia gene and its genomic organization
US58694451 avr. 19969 févr. 1999University of WashingtonMethods for eliciting or enhancing reactivity to HER-2/neu protein
US587442312 sept. 199623 févr. 1999Yissum Research Development Co. of the Hebrew University of JerusalemDigitalis-like compounds
US58767126 juin 19952 mars 1999University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US591675226 sept. 199729 juin 1999Arch Development CorporationTelomerase screening methods
US60751226 juin 199513 juin 2000University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US61875634 août 199913 févr. 2001Yale University.beta.IV-spectrin-polypeptides and nucleic acids encoding same
US62007493 mai 199613 mars 2001Ramot-University Authority for Applied Research and Industrial Development Ltd.Mutated forms of the ataxia-telangiectasia gene and method to screen for a partial A-T phenotype
US620075521 juil. 199813 mars 2001Burstein Technologies, Inc.Optical disk-based assay devices and methods
US62844962 janv. 19984 sept. 2001University of South FloridaDNA vector for determining the presence of out-of-reading-frame mutations
US631290110 sept. 19996 nov. 2001Burstein Technologies, Inc.Spatially addressable, cleavable reflective signal elements, assay device and method
US63312753 août 200018 déc. 2001Burstein Technologies, Inc.Spatially addressable, cleavable reflective signal elements, assay device and method
US634234921 juil. 199829 janv. 2002Burstein Technologies, Inc.Optical disk-based assay devices and methods
US63444438 juil. 19995 févr. 2002University of South FloridaPeptide antagonists of tumor necrosis factor alpha
US638761930 juin 199914 mai 2002Arch DevelopmentTelomerase compositions and methods
US63915638 déc. 199321 mai 2002Akzo Nobel N.V.Method for the determination of antigens with the aid of three or more monoclonal antibodies
US64069207 août 199618 juin 2002Inverness Medical Switzerland GmbHProcesses and apparatus for carrying out specific binding assays
US644068224 mai 200027 août 2002Detroit R&D Inc.Detection of hypertension using immunoreactive metabolic products
US64823892 juin 200019 nov. 2002University of South FloridaMethod to diagnose and monitor cellular immune deficiencies
US653127719 mars 199811 mars 2003The Curators of the University of MissouriEndometriosis-specific secretory protein
US661083815 sept. 199826 août 2003Symbicom AktiebolagP13 antigens from Borrelia
US665647116 nov. 19992 déc. 2003Board of Regents, The University of Texas SystemHIV-specific T-cell induction
US666437015 juil. 199916 déc. 2003University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US668975728 déc. 199810 févr. 2004M.L. Laboratories PLCMethods for vaccination and vaccines therefor
US674073823 déc. 200225 mai 2004Quark Biotech, Inc.Antibody against hypoxia proteins
US67706228 juin 20013 août 2004N-terminally truncated galectin-3 for use in treating cancer
US67873181 juin 20007 sept. 2004Roskamp Research Institute, LLCAssay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US686700524 oct. 200115 mars 2005Beckman Coulter, Inc.Method and apparatus for increasing the dynamic range and accuracy of binding assays
US687558218 août 20005 avr. 2005OmniScience Pharmaceuticals, Inc.Methods and targets of antibiotic resistance
US69535736 oct. 199811 oct. 2005University of WashingtonCompounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US699217613 févr. 200231 janv. 2006Technion Research & Development Foundation Ltd.Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
US69982324 avr. 200114 févr. 2006Quark Biotech, Inc.Methods of diagnosing bladder cancer
US703374711 avr. 200225 avr. 2006Nagaoka & Co., LTD
Burstein Technologies, Inc.
Multi-parameter assays including analysis discs and methods relating thereto
US70604621 nov. 200113 juin 2006National University of SingaporeAopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display
US708739516 janv. 20018 août 2006Quest Diagnostics Investments IncorporatedVitamin D assay
US710183929 août 20005 sept. 2006Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US71381449 sept. 200221 nov. 2006Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
US722390215 nov. 200029 mai 2007Yissum Research Development Company of the Hebrew University of JerusalemMethod of producing recombinant Aspergillus niger β-glucosidase and an aroma spreading plant
US724770321 août 200324 juil. 2007University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US727081028 déc. 200018 sept. 2007Yeda Research and Development Co. Ltd.Veto cells effective in preventing graft rejection and devoid of graft versus host potential
US72947012 avr. 200313 nov. 2007Technion Research & Development Foundation Ltd.Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
US730680429 sept. 200311 déc. 2007Board of Regents, the University of Texas SystemHIV-specific T-cell induction
US730680429 sept. 200311 déc. 2007Board of Regents, the University of Texas SystemHIV-specific T-cell induction
US734797222 juil. 199825 mars 2008Multiple analyte assay device
US73550795 avr. 20058 avr. 2008The Regents of the University of California
Oregon Health & Science University
Thyronamine derivatives and analogs and methods of use thereof
US738510610 janv. 200110 juin 2008Ramot At Tel Aviv University Ltd.Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
US742313920 janv. 20049 sept. 2008InSight Biopharmaceuticals Ltd.High level expression of recombinant human erythropoietin having a modified 5′-UTR
US744278115 août 200228 oct. 2008Urifer Ltd.Diagnosis, prevention and treatment of cancer
US749842820 juin 20043 mars 2009Evogene Ltd.Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US753460517 mai 200519 mai 2009Yissum Research Development Company of the Hebrew University of JerusalemCD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US753460911 avr. 200519 mai 2009Pluristem Life Systems Inc.Method of expanding undifferentiated hemopoietic stem cells
US75539401 févr. 200730 juin 2009Modigene IncLong-acting EPO polypeptides and derivatives thereof and methods thereof
US75539411 févr. 200730 juin 2009Modigene IncLong-acting polypeptides and methods of producing same
US755400722 nov. 200530 juin 2009Evogene Ltd.Methods of increasing abiotic stress tolerance and/or biomass in plants
US76016973 mai 200513 oct. 2009University of WashingtonCompounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US760514913 juil. 199920 oct. 2009University of South FloridaModulation of the phospholipase A2 pathway as a therapeutic
US761172320 mars 20033 nov. 2009NanoCyte Inc.Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US762570727 sept. 20041 déc. 2009Ramot At Tel Aviv University Ltd.Antibacterial agents and methods of identifying and utilizing same
US763252210 janv. 200615 déc. 2009NanoCyte Inc.Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US76329239 mars 200515 déc. 2009Technion Research & Development Foundation Ltd.Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
US763812425 mars 200429 déc. 2009Technion Research & Development Foundation Ltd.Antigen-presenting complex-binding compositions and uses thereof
US765522519 févr. 20082 févr. 2010Gamida Cell, Ltd.Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
US765523921 juin 20072 févr. 2010University of WashingtonImmune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
US767857311 avr. 200516 mars 2010Pluristem Ltd.Method of preparing a conditioned medium from a confluent stromal cell culture
US768705717 déc. 200230 mars 2010Yissum Research Development Company of the Hebrew University of JerusalemIn vitro micro-organs, and uses related thereto
US769592717 mars 200613 avr. 2010Detroit R & DDetection of hypertension using glucuronidated metabolic products
US771877718 oct. 200618 mai 2010Technion Research & Development Foundation Ltd.MHC-peptide complex binding ligands
US778139621 juin 200624 août 2010Tel Aviv University Future Technology Development L.P.Peptides directed for diagnosis and treatment of amyloid-associated disease
US778140211 oct. 200524 août 2010Closed Loop Therapies Ltd.Methods and implantable devices for treating supraventricular arrhythmias
US778626731 janv. 200831 août 2010Baylor Research InstituteMultivariable antigens complexed with targeting humanized monoclonal antibody
US779067312 juin 20067 sept. 2010New York UniversityMethods and compositions relating to cystatin C
US781198129 sept. 200412 oct. 2010Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US785507519 mai 200821 déc. 2010Gamida Cell Ltd.
Hadasit Medical Research Services and Development Ltd.
Methods of controlling proliferation and differentiation of stem and progenitor cells
US78880032 sept. 200515 févr. 2011The United States of America as represented by the Department of Health and Human ServicesMethods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
US789324025 juil. 200822 févr. 2011InSight Biopharmaceuticals Ltd.High level expression of recombinant human erythropoietin having a modified 5′-UTR
US791080015 août 200622 mars 2011Evogene Ltd.Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
US792808316 janv. 200819 avr. 2011Yissum Research Development Company of the Hebrew University of JerusalemH19 silencing nucleic acid agents for treating rheumatoid arthritis
US794749930 nov. 200324 mai 2011Technion Research & Development Foundation Ltd.Method of dynamically culturing embryonic stem cells
US79558529 févr. 20047 juin 2011Gamida Cell Ltd.Expansion of renewable stem cell populations
US800090030 déc. 200516 août 2011Microsoft CorporationAssociation-based predictions of pathogen characteristics
US80078477 août 200630 août 2011Eytan BidermanFeeding formula appliance
US80129292 juil. 20096 sept. 2011Tel Aviv University Future Technology Development L.P.Peptides directed for diagnosis and treatment of amyloid-associated diseases
US80175865 janv. 200913 sept. 2011Ramot at Tel-Aviv University Ltd.Peptide nanostructures encapsulating a foreign material and method of manufacturing same
US801981816 janv. 200713 sept. 2011Zlango Ltd.Communications network system and methods for using same
US803491421 sept. 200611 oct. 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
US803924028 sept. 200518 oct. 2011Yissum Reseach Development Company of the Hebrew University of JerusalemRecombinant human T2 RNase and uses thereof
US80535542 janv. 20098 nov. 2011Ramot at Tel-Aviv University Ltd.Peptide nanostructures and methods of generating and using the same
US80577981 févr. 200815 nov. 2011Baylor Research InstituteVaccines based on targeting antigen to DCIR expressed on antigen-presenting cells
US806266015 mars 200622 nov. 2011NanoCyte Inc.Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
US80675736 juil. 200629 nov. 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid agents for downregulating H19 and methods of using same
US806757416 janv. 200829 nov. 2011Yissum Research Development Company of the Hebrew University of JerusalemNucleic acid agents for downregulating H19, and methods of using same
US80713236 avr. 20076 déc. 2011The United States of America as represented by the Secretary of the Department of Health and Human ServicesHuman monoclonal antibodies that bind human insulin like growth factors and their use
US808041729 nov. 200620 déc. 2011Gamida-Cell Ltd.Methods of ex vivo hematopoietic stem cell expansion by co-culture with mesenchymal cells
US80881602 juin 20093 janv. 2012Multi-Gene Vascular Systems Ltd. (“MGVS”)Drug-eluting intravascular prostheses and methods of use
US81295149 févr. 20096 mars 2012Evogene Ltd.Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US815338318 mars 200910 avr. 2012Wisconsin Alumni Research FoundationMycobacterial culture screening test for Mycobacterium avium complex bacteria
US815837114 oct. 201017 avr. 2012Wisconsin Alumni Research FoundationAssay for antibodies to Mycobacterium paratuberculosis
US816349427 nov. 200324 avr. 2012Technion Research & Development Foundation Ltd.Method for assessing metastatic properties of breast cancer
US816818030 sept. 20091 mai 2012Technion Research & Development Foundation Ltd.Methods and compositions for modulating angiogenesis
US816885720 déc. 20071 mai 2012Evogene Ltd.Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US81781285 déc. 200215 mai 2012Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Nanoparticles containing polymeric nucleic acid homologs
US81933117 févr. 20115 juin 2012Yissum Research Development Company of the Hebrew University of JerusalemCD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
US82027246 oct. 201019 juin 2012Gamida Cell Ltd.
Hadasit Medical Research Services and Development Ltd.
Methods of controlling proliferation and differentiation of stem and progenitor cells
US823654327 sept. 20107 août 2012Yissum Research Development Company of the Hebrew University of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US82369342 févr. 20087 août 2012Baylore Research InstituteAgents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
USRE310062 mars 19783 août 1982Akzona IncorporatedProcess for the demonstration and determination of reaction components having specific binding affinity for each other
USRE3269622 déc. 197814 juin 1988Akzona IncorporatedEnzymatic immunological method for determination of antigens and antibodies